Table 1.
Indication for ECLS support comparing in house implantation (Home) vs. external implantations (Transport)
| Indication for ECLS | all | Home | Transport | p |
|---|---|---|---|---|
| Total | 978 (100) | 733 | 243 | |
| Pneumonia | 292 (30) | 189 (26) | 102 (42) | p < 0.001 |
| Influenca A | 48 (5) | 30 (4) | 18 (7) | p = 0.32 |
| ARDS | 425 (44) | 286 (39) | 138 (57) | p = < 0.001 |
| Lungfibrosis | 33 (3) | 30 (4) | 3 (1) | p = 0.038 |
| Pulmonary hypertension | 43 (4) | 35 (5) | 8 (3) | p = 0.216 |
| Cystic fibrosis | 29 (3) | 25 (3) | 4 (2) | p = 0.373 |
| Lung embolia | 50 (5) | 39 (5) | 11 (5) | p = 0.384 |
| PMR/VSD/ASD | 29 (3) | 19 (3) | 10 (4) | p = 0.160 |
| Myocardial infarction (NSTEMI, STEMI) | 118 (12) | 83 (11) | 35 (14) | p = 0.212 |
| DCM | 80 (8) | 64 (9) | 15 (6) | p = 0.224 |
| Myocarditis | 26 (3) | 15 (2) | 11 (5) | p = 0.062 |
| Peripartum cardiomyopathy | 5 (0.5) | 2 (0.3) | 3 (1) | p = 0.224 |
| Polytrauma | 21 (2) | 13 (2) | 8 (3) | p = 0.102 |
| Sepsis | 49 (5) | 49 (7) | 0 | p < 0.001 |
| post DLTX | 30 (3) | 30 (4) | 0 | p < 0.001 |
| Postcardiectomie | 2 (0.2) | 2 (0.3) | 1 (0.4) | p = 0.564 |
| Burn | 16 (2) | 16 (2) | 0 | p = 0.410 |
| Post HTX | 20 (2) | 20 (3) | 4 (2) | p = 0.006 |
| Cardiac failure after VAD | 34 (4) | 33 (5) | 1 (0.4) | p = 0.001 |
| Postcardiotomie | 109 (11) | 108 (15) | 1 (0.4) | p < 0.001 |
| Others | 92 (9) | 83 (11) | 9 (4) | p < 0.001 |
ARDS: acute respiratory distress syndrome, PMR: Papillary muscle rupture, VSD: ventricular septum defect, ASD: atrial septum defect